Please login to the form below

Not currently logged in
Email:
Password:

licenses

This page shows the latest licenses news and features for those working in and with pharma, biotech and healthcare.

FDA accepts Regeneron’s REGEN-COV for priority review for treatment of COVID-19

FDA accepts Regeneron’s REGEN-COV for priority review for treatment of COVID-19

Regeneron Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) for priority review of REGEN-COV (casirivimab and imdevimab) to treat

Latest news

More from news
Approximately 1 fully matching, plus 468 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 53 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....